| Literature DB >> 24984066 |
Chih-Ching Yang1, Chien-An Yao2, Yi-Ruu Lin3, Jyh-Chin Yang4, Chiang-Ting Chien5.
Abstract
Deep-sea water (DSW), which is rich in micronutrients and minerals and with antioxidant and anti-inflammatory qualities, may be developed as marine drugs to provide intestinal protection against duodenal ulcers. We determined several characteristics in the modified DSW. We explored duodenal pressure, oxygenation, microvascular blood flow, and changes in pH and oxidative redox potential (ORP) values within the stomach and duodenum in response to tap water (TW, hardness: 2.48 ppm), DSW600 (hardness: 600 ppm), and DSW1200 (hardness: 1200 ppm) in Wistar rats and analyzed oxidative stress and apoptosis gene expressions by cDNA and RNA microarrays in the duodenal epithelium. We compared the effects of drinking DSW, MgCl2, and selenium water on duodenal ulcers using pathologic scoring, immunohistochemical analysis, and Western blotting. Our results showed DSW has a higher pH value, lower ORP value, higher scavenging H2O2 and HOCl activity, higher Mg2+ concentrations, and micronutrients selenium compared with TW samples. Water infusion significantly increased intestinal pressure, O2 levels, and microvascular blood flow in DSW and TW groups. Microarray showed DSW600, DSW1200, selenium water upregulated antioxidant and anti-apoptotic genes and downregulated pro-apoptotic gene expression compared with the TW group. Drinking DSW600, DSW1200, and selenium water but not Mg2+ water significantly enhanced Bcl-2 and thioredoxin reductase 1 expression. Bax/Bcl-2/caspase 3/poly-(ADP-ribose)-polymerase signaling was activated during the pathogenesis of duodenal ulceration. DSW drinking reduced ulcer area as well as apoptotic signaling in acetic acid-induced duodenal ulcers. DSW, which contains selenium, provides intestinal protection against duodenal ulcers through the upregulation of Bcl-2 and thioredoxin reductase 1.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24984066 PMCID: PMC4077573 DOI: 10.1371/journal.pone.0096006
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
The characteristics of pH, ORP, antioxidant activity, and mineral contents of the different types of water studied.
| TW | DSW600 | DSW1200 | |
| pH | 6.68 | 7.01 | 7.29 |
| ORP (mV) | 344 | 203 | 125 |
| H2O2-CL counts (counts/10 s) | 1.20±0.42 (×107) | 5.82±1.90 (×106) | 1.72±0.54 (×106) |
| HOCl CL counts(counts/10 µs) | 3.11±0.62 (×105) | 1.09±0.34 (×105) | 5.21±1.63 (×104) |
| Na (mg/dL) | 0.45 | 368 | 738 |
| K (mg/dL) | 0.11 | 67 | 133 |
| Ca (mg/dL) | 0.21 | 1.02 | 2.08 |
| Mg (mg/dL) | 0.35 | 225 | 448 |
| Mg/Ca | 1.66 | 220 | 215 |
| Hardness (ppm) | 2.1 | 589 | 1185 |
| Selenium (µg/L) | ND | 0.0011 | 0.0023 |
| As (µg/L) | ND | ND | ND |
| Cr (µg/L) | ND | ND | ND |
| Ba (µg/L) | ND | ND | ND |
| Cd (µg/L) | ND | ND | ND |
| Pb (µg/L) | ND | ND | ND |
| Hg (µg/L) | ND | ND | ND |
ND: not detectable in our samples.
Figure 1The characteristics of pH and ORP values of water solution before and after the stomach and duodenum.
The setup for the measurement of changes in pH and ORP values of the tap water (TW) or deep-sea water (DSW) solution after passing through the stomach (A) or duodenum (C). The statistical data relating to pH and ORP values before and after stomach or duodenum pathway are displayed in B and D, respectively. BSTW = TW before passing through the stomach; ASTW = TW after passing through the stomach; BSDSW = DSW before passing through the stomach; ASDSW = DSW after passing through the stomach; BDTW = TW before passing through the duodenum; ADTW = TW after passing through the duodenum; BDDSW = DSW before passing through the duodenum; ADDSW = DSW after passing through the duodenum.
Expression of oxidative stress genes in the duodenal epithelium after water restriction (WR), DSW intake and TW intake.
| Gene | Description | Fold Up- or Down-regulation |
|
| ||
|
| Flavin containing monooxygenase 2 | −2.66 |
|
| Ferritin, heavy polypeptide 1 | −1.71 |
|
| Glutathione reductase | −1.55 |
|
| Peroxiredoxin 4 | −2.11 |
|
| Proteasome (prosome, macropain) subunit, beta type 5 | −1.62 |
|
| Superoxide dismutase 1, soluble | −2.09 |
|
| ||
|
| Parkinson disease (autosomal recessive, early onset) 7 | +2.65 |
|
| Prion protein | +2.58 |
|
| Sulfiredoxin 1 homolog ( | +2.15 |
|
| Thioredoxin reductase 1 | +1.73 |
|
| ||
|
| Apolipoprotein E | +4.45 |
|
| Dynamin 2 | +3.86 |
|
| Dual oxidase 1 | +3.02 |
|
| EH-domain containing 2 | +3.87 |
|
| Excision repair cross-complementing rodent repair deficiency, complementation group 2 | +5.97 |
|
| Fanconi anemia, complementation group C | +5.29 |
|
| Flavin containing monooxygenase 2 | +4.11 |
|
| Glutathione peroxidase 1 | +3.67 |
|
| Glutathione peroxidase 5 | +3.33 |
|
| Glutathione peroxidase 6 | +3.91 |
|
| Glutathione reductase | +3.81 |
|
| Neuroglobin | +4.06 |
|
| Nitric oxide synthase 2, inducible | +3.01 |
|
| Parkinson disease (autosomal recessive, early onset) 7 | +3.99 |
|
| Peroxiredoxin 4 | +3.04 |
|
| Peroxiredoxin 4 | +2.70 |
|
| Selenoprotein P, plasma, 1 | +2.60 |
|
| Sulfiredoxin 1 homolog (S. cerevisiae) | +2.77 |
|
| Thioredoxin interacting protein | +2.22 |
|
| Thioredoxin reductase 1 | +2.61 |
|
| ||
|
| Amyotrophic lateral sclerosis 2 (juvenile) homolog (human) | +1.51 |
|
| Adenomatous polyposis coli | −1.12 |
|
| Catalase | +1.62 |
|
| Chemokine (C-C motif) ligand 5 | −5.63 |
|
| Copper chaperone for superoxide dismutase | +3.32 |
|
| Cathepsin B | +1.13 |
|
| Cytochrome b-245, alpha polypeptide | +5.48 |
|
| 24-dehydrocholesterol reductase | +5.56 |
|
| Dynamin 2 | +6.34 |
|
| Excision repair cross-complementing rodent repair deficiency, complementation group 2 | −2.19 |
|
| Ferritin, heavy polypeptide 1 | −1.98 |
|
| Glutamate-cysteine ligase, catalytic subunit | +1.37 |
|
| Glutamate cysteine ligase, modifier subunit | +1.47 |
|
| Glutathione peroxidase 1 | +4.00 |
|
| Glutathione peroxidase 2 | +5.05 |
|
| Glutathione peroxidase 3 | −1.18 |
|
| Glutathione peroxidase 4 | +2.80 |
|
| Glutathione reductase | +2.12 |
|
| Glutathione S-transferase kappa 1 | +1.39 |
|
| Glutathione S-transferase pi 1 | +1.59 |
|
| Hemoglobin alpha, adult chain 2 | +1.02 |
|
| Heme oxygenase (decycling) 1 | −2.55 |
|
| Isocitrate dehydrogenase 1 (NADP+), soluble | +1.56 |
|
| NADPH oxidase activator 1 | −1.22 |
|
| NAD(P)H dehydrogenase, quinone 1 | +1.49 |
|
| Parkinson disease (autosomal recessive, early onset) 7 | +2.23 |
|
| Peroxiredoxin 1 | −2.96 |
|
| Peroxiredoxin 2 | −1.62 |
|
| Peroxiredoxin 3 | −1.28 |
|
| Peroxiredoxin 4 | −1.49 |
|
| Peroxiredoxin 5 | +2.73 |
|
| Peroxiredoxin 6 | +8.00 |
|
| Prion protein | +2.57 |
|
| Proteasome (prosome, macropain) subunit, beta type 5 | −1.47 |
|
| Prostaglandin-endoperoxide synthase 1 | −1.12 |
|
| Selenoprotein S | −2.30 |
|
| Selenoprotein P, plasma, 1 | +2.16 |
|
| Serine (or cysteine) peptidase inhibitor, clade B, member 1b | −3.03 |
|
| Solute carrier family 38, member 1 | +2.97 |
|
| Superoxide dismutase 1, soluble | −1.49 |
|
| Superoxide dismutase 2, mitochondrial | +1.78 |
|
| Sequestosome 1 | +9.79 |
|
| Sulfiredoxin 1 homolog (S. cerevisiae) | +2.62 |
|
| Thioredoxin 1 | −3.32 |
|
| Thioredoxin interacting protein | +6.56 |
|
| Thioredoxin reductase 1 | +4.61 |
|
| Thioredoxin reductase 2 | −1.73 |
|
| Uncoupling protein 2 (mitochondrial, proton carrier) | +13.03 |
Fold-Change [2∧(−Delta Delta Ct)] is the normalized gene expression [2∧(−Delta Ct)] in the test sample divided by the normalized gene expression [2∧(−Delta Ct)] in the control sample.
Expression of apoptotic genes in the duodenal epithelium after water restriction, intake of DSW waters vs intake of TW.
| Gene | Description | Fold Up- or Down-regulation |
|
| ||
|
| Apoptosis-inducing factor, mitochondrion-associated 1 | +1.64 |
|
| Apoptosis inhibitor 5 | +1.69 |
|
| BCL2-associated athanogene | +1.45 |
|
| BCL2-associated agonist of cell death | +1.24 |
|
| Bcl2-associated X protein | +1.55 |
|
| Caspase 1 | +1.24 |
|
| Cell death-inducing DFFA-like effector b | +2.26 |
|
| Cytochrome c, somatic | +3.52 |
|
| Fas (TNF receptor superfamily, member 6) | +1.70 |
|
| Growth arrest and DNA-damage-inducible, alpha | −1.12 |
|
| Mitogen activated protein kinase 1 | +1.34 |
|
| PYD and CARD domain containing | +2.03 |
|
| X-linked inhibitor of apoptosis | +1.36 |
|
| ||
|
| Apoptosis-inducing factor, mitochondrion-associated 1 | +1.25 |
|
| Apoptosis inhibitor 5 | −1.14 |
|
| BCL2-associated athanogene | −1.15 |
|
| Cell death-inducing DFFA-like effector b | −1.32 |
|
| Cytochrome c, somatic | −1.59 |
|
| Fas (TNF receptor superfamily, member 6) | −1.01 |
|
| Growth arrest and DNA-damage-inducible, alpha | +1.01 |
|
| Mitogen activated protein kinase 1 | −1.35 |
|
| Myeloid cell leukemia sequence 1 | +1.39 |
|
| PYD and CARD domain containing | −1.71 |
|
| X-linked inhibitor of apoptosis | +1.26 |
|
| ||
|
| Apoptosis-inducing factor, mitochondrion-associated 1 | −1.02 |
|
| Apoptosis inhibitor 5 | −1.39 |
|
| BCL2-associated athanogene | −1.21 |
|
| Cell death-inducing DFFA-like effector b | −1.43 |
|
| Cytochrome c, somatic | −1.90 |
|
| Fas (TNF receptor superfamily, member 6) | +1.06 |
|
| Growth arrest and DNA-damage-inducible, alpha | +1.04 |
|
| Mitogen activated protein kinase 1 | −1.14 |
|
| Myeloid cell leukemia sequence 1 | +1.04 |
|
| PYD and CARD domain containing | −1.54 |
|
| ||
|
| Apoptosis-inducing factor, mitochondrion-associated 1 | +3.35 |
|
| Apoptosis inhibitor 5 | +2.25 |
|
| BCL2-associated athanogene | +4.24 |
|
| Caspase 1 | +4.21 |
|
| Cell death-inducing DFFA-like effector b | +4.49 |
|
| Cytochrome c, somatic | +2.53 |
|
| Fas (TNF receptor superfamily, member 6) | +2.57 |
|
| Growth arrest and DNA-damage-inducible, alpha | +7.19 |
|
| Mitogen activated protein kinase 1 | +5.29 |
|
| Myeloid cell leukemia sequence 1 | +4.13 |
|
| PYD and CARD domain containing | +1.61 |
|
| X-linked inhibitor of apoptosis | +4.90 |
Fold-Change [2∧(−Delta Delta Ct)] is the normalized gene expression [2∧(−Delta Ct)] in the test sample divided by the normalized gene expression [2∧(−Delta Ct)] in the control sample.
Figure 2Effect of water infusion on intestinal pressure, microvascular blood flow and oxygen concentration.
The typical recordings (A) and statistical data (B) relating to changes in arterial blood pressure (ABP), intestinal pressure (IP), duodenal microvascular blood flow (DMVBF) and partial oxygen concentration in the duodenum in response to tap water (TW) or deep-sea water (DSW) infusion. C = control stage; I = intestinal infusion of TW or DSW; R = recovery stage after infusion. *P<0.05 vs. control stage.
Figure 3The comparison of different waters consumption on acetic acid-induced duodenal injury.
Effect of one-week consumption of tap water (TW), deep-sea water (DSW), magnesium water (MgW) or selenium water (SeW) on acetic acid-induced duodenal ulcers and apoptosis in rats. The ulcer area is indicated with blue arrows (a–j) and the statistical data relating to the ulcers are indicated as k. Apoptosis formation is indicated with red arrows (l–u) and statistical data relating to apoptosis is summarized in°v. Con TW = control group with TW (black bar); Con DSW = control group with DSW1200 (white bar); D1TW = day 1 ulcer with TW; D3TW = day 3 ulcer with TW; D1DSW600 = day 1 ulcer with DSW600; D3DSW600 = day 3 ulcer with DSW600; D1DSW1200 = day 1 ulcer with DSW1200; D3DSW1200 = day 3 ulcer with DSW1200; D1MgW = day 1 ulcer with MgCl2 in DDW; D3MgW = day 3 ulcer with MgCl2 in DDW; D1SeW = day 1 ulcer with Se in DDW; D3SeW = day 3 ulcer with Se in DDW;. *P<0.05 vs. respective D1 group. #P<0.05 vs. D3TW group.
Figure 4Effect of different water drinking on apoptotic- and antioxidant-related mRNA and protein expression in duodenal tissue.
A: Duodenal bad mRNA (in circle) expression in response to WR, tap water (TW) and DSW1200. The statistical data is shown in A-1. B: Duodenal bax mRNA (in circle) expression in response to WR, TW, and DSW1200. The statistical data is shown in B-1. C: The original data relating to duodenal Txnrd1, Bcl-2, and Bax protein expression in response to TW, MgW with 225 mg/L or 450 mg/L, SeW with selenium 1 mg/100 mL, WR, DSW600, and DSW1200. Statistical data relating to Txnrd1 (C-1), Bcl-2 (C-2), and Bax (C-3) is also demonstrated. D: Effect of one week of TW or DSW consumption on the apoptotic- and antioxidant-related protein expression in acetic acid-induced duodenal ulcers. The statistical data relating to Txnrd1 (D-1), Bcl-2 (D-2), Bax (D-3), caspase 3 (D-4), and PARP (D-5) is indicated. TW = tap water; D1TW = day 1 ulcer with TW; TW = Day 3 ulcer with TW; DSW = deep-sea water; D1DSW = day 1 ulcer with DSW; D3DSW = day 3 ulcer with DSW. MgW = 225 mg/L or 450 mg/L of MgCl2 in distilled water (DW); SeW = 1 mg/L of sodium selenite in DW. *P<0.05 vs. respective TW group.
Figure 5The effect of DSW on H. pylori growth.
The experimental data are obtained from three independent tests. *P<0.05 vs. hardness at 0.